- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03845478
Effect of the Prescription of 10,000 Steps Per Day Using a Pedometer APP in the Body Composition of Overweight Adults
Effect of the Prescription of 10,000 Steps a Day Using a Pedometer Via Mobile APP, Through a Goal Setting System, in the Body Composition of Overweight Adults: a 6-Month Randomized Weight Loss and mHealth Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The promotion of the increase in (FA) should be a priority in the treatment of weight loss in overweight or obese subjects. Walking is a solution to overcome physical inactivity, due to its low impact in which the person can control the intensity, duration and effort in order to reduce the risk of injury.
Monitoring the AF through the number of steps / day offers the possibility of standardizing the evaluation and monitoring. Although the goal of 10,000 steps a day may not be appropriate at various levels of age and physical condition, it is considered a reasonable and motivating goal for healthy adults and previous studies have demonstrated its effectiveness in weight loss programs.
The objective of this study is to compare the effect of the implementation of a monitoring system, goal to achieve, on physical activity in overweight and obese adults. Both groups, control and intervention, have a prescription of 10,000 steps a day to reach, but only the intervention group will have a control system, messages of encouragement and follow-up.
Participants (n=120) will be recruited through outpatient from private clinics in Cádiz, Andalucía, Spain, as well as through community presentations. Overweight or obese and sedentary adult will be randomly assigned into two groups.
For 6 months, all of the adults shall follow the same diet with an identical distribution of macronutrients. There will be a weekly check up of weight, fat, body water and muscle mass for all of them. The status of the number of steps in Accupedo is also checked every week
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Having a IMC >25,
- Being sedentary and
- Have not been submitted to a restrictive diet in the 6 months preceding this study.
Exclusion Criteria:
- Suffered from type 2 diabetes or renal conditions
- Being pregnancy or attempt at pregnancy,
- Being in a maternal lactation period,
- Being underage
- Undergoing antidepressant pharmacological treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Group (CG)
Education, modifying diet and physical activity
|
The control group is subjected to follow a hypocaloric diet and receives information about the benefits of achieving 10,000 steps a day in weight loss and improved body composition.
|
|
Experimental: Intervention Group (IG)
Education and modifying diet and physical activity with prescription and goal setting
|
This group in addition to fulfilling a hypocaloric diet identical to the control group, and receive identical information about physical activity that the control group, it has a system of prescription, monitoring and establishing an objective to achieve 10,000 steps a day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to dietary pattern will be also measured through personal interview
Time Frame: At baseline (0 years) and followed for 2 years
|
Participants will be subjected for an intervention based on nutritional (control group) and physical education (two intervention arms) during 24 months.
Partial measures will be also taken every week.
In the end of the trial, changes in dietary patterns will be measured comparing means differences between baselines, 3, 6, 12 and 24 months.
|
At baseline (0 years) and followed for 2 years
|
|
Changes from baseline BMI
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean BMI values will be measured and compared at 3, 6, 12 and 24 months.
BMI will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale
|
At baseline (0 years) and followed for 2 years
|
|
Changes from baseline Fatty mass
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean Fatty mass values will be measured and compared at 3, 6, 12 and 24 months.
Fatty mass will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale.
Fatty mass is measured as a percentage.
|
At baseline (0 years) and followed for 2 years
|
|
Changes from baseline Free-fatty mass
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean Free-fatty mass values will be measured and compared at 3, 6, 12 and 24 months.
Free-fatty mass will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale.
Fatty mass is measured as a percentage.
|
At baseline (0 years) and followed for 2 years
|
|
Changes from baseline Muscular Mass
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean Muscular Mass values will be measured and compared at 3, 6, 12 and 24 months.
Muscular Mass will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale.
Fatty mass is measured as a Kg.
|
At baseline (0 years) and followed for 2 years
|
|
Changes from baseline Corporal Water
Time Frame: At baseline (0 years) and followed for 2 years
|
Baseline mean Corporal Water values will be measured and compared at 3, 6, 12 and 24 months.
Corporal Water will be assessed on a monthly basis during nutritional consultation through a Bioelectrical Impedance Analysis method using a Tanita BC-418 Segmental Body Composition Analyser/Scale.
Fatty mass is measured as a Kg.
|
At baseline (0 years) and followed for 2 years
|
|
Adherence to physical activity patterns will be also measured through IPAQ (International Physical Activity Questionnaire)
Time Frame: At baseline (0 years) and followed for 2 years
|
Participants will be subjected for an intervention based on nutritional (control group) and physical education (two intervention arms) during 24 months.
Partial measures will be also taken every week.
In the end of the trial, changes in physical activity will be measured comparing means differences between baselines, 3, 6, 12 and 24 months.
|
At baseline (0 years) and followed for 2 years
|
|
Changes from baseline in the number of steps per day
Time Frame: At baseline (0 years) and followed for 2 years
|
Daily step-counts will be measured using Accupedo Pedometer app; this app can give feedback on distance, time and speed, and and average steps per day, week and month.
Accupedo.
Partial measures will be also taken every week.
In the end of the trial, changes in physical activity patterns will be measured comparing means differences between baselines, 3, 6, 12 and 24 months.
|
At baseline (0 years) and followed for 2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alberto Hernández-Reyes, Universidad de Córdoba
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- A284R4156
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on Control Group (CG)
-
Universiti Putra MalaysiaNot yet recruitingCardiometabolic SyndromeMalaysia
-
Fundación Pública Andaluza para la Investigación...University of MalagaUnknownDepression | Type 1 Diabetes MellitusSpain
-
Istanbul Arel UniversityCompletedShoulder Impingement Syndrome | Trigger Point PainTurkey
-
Novindiet ClinicTehran University of Medical Sciences; University of NottinghamCompletedObesity | OverweightIran, Islamic Republic of
-
Universidad de CórdobaUnknownOverweight and Obesity | Signs and Symptoms | Behavior, EatingSpain
-
Mieko Cláudia MiuraHospital do CoracaoCompleted
-
University of VirginiaRivanna Medical, LLCCompleted
-
Washington University School of MedicineSpinal Cord Injury/Disease Research ProgramCompleted
-
University of Sao PauloCompleted
-
University of SevilleCompleted